BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Merikhian P, Ghadirian R, Farahmand L, Mansouri S, Majidzadeh-a K. MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancer. Expert Review of Anticancer Therapy 2017;17:607-13. [DOI: 10.1080/14737140.2017.1340837] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Dalil D, Iranzadeh S, Kohansal S. Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative review. Front Pharmacol 2022;13:979634. [DOI: 10.3389/fphar.2022.979634] [Reference Citation Analysis]
2 Song Y, Feng T, Cao W, Yu H, Zhang Z. Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis. Comput Intell Neurosci 2022;2022:9022700. [PMID: 35712071 DOI: 10.1155/2022/9022700] [Reference Citation Analysis]
3 Northey JJ, Weaver VM. Mechanosensitive steroid hormone signaling and cell fate. Endocrinology 2022:bqac085. [PMID: 35678467 DOI: 10.1210/endocr/bqac085] [Reference Citation Analysis]
4 Hosseinzadeh A, Merikhian P, Naseri N, Eisavand MR, Farahmand L. MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02523-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Brandão DC, Lima PMAP, Martins IC, Cordeiro CS, Cordeiro AO, Vecchi L, Guerra JFC, Orsolin PC, Gazolla MC, Costa DS, da Silva Filho AA, Araújo TG. Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells. BMC Complement Med Ther 2022;22. [DOI: 10.1186/s12906-022-03506-3] [Reference Citation Analysis]
6 Kadkhoda J, Aghanejad A, Safari B, Barar J, Rasta SH, Davaran S. Aptamer-conjugated gold nanoparticles for targeted paclitaxel delivery and photothermal therapy in breast cancer. Journal of Drug Delivery Science and Technology 2022;67:102954. [DOI: 10.1016/j.jddst.2021.102954] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
7 Merikhian P, Darvishi B, Jalili N, Esmailinejad MR, Khatibi AS, Kalbolandi SM, Salehi M, Mosayebzadeh M, Barough MS, Majidzadeh-A K, Yadegari F, Rahbarizadeh F, Farahmand L. Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors. Mol Oncol 2021. [PMID: 34694686 DOI: 10.1002/1878-0261.13123] [Reference Citation Analysis]
8 Ganguly S, Arora I, Tollefsbol TO. Impact of Stilbenes as Epigenetic Modulators of Breast Cancer Risk and Associated Biomarkers. Int J Mol Sci 2021;22:10033. [PMID: 34576196 DOI: 10.3390/ijms221810033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Merikhian P, Eisavand MR, Farahmand L. Triple-negative breast cancer: understanding Wnt signaling in drug resistance. Cancer Cell Int 2021;21:419. [PMID: 34376211 DOI: 10.1186/s12935-021-02107-3] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
10 Khodabakhsh F, Merikhian P, Eisavand MR, Farahmand L. Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling. Cancer Cell Int 2021;21:200. [PMID: 33836774 DOI: 10.1186/s12935-021-01899-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Mansouri S, Mokhtari-Hesari P, Naghavi-Al-Hosseini F, Seyednejad SA, Majidzadeh-A K, Moradi-Kalbolandi S, Ghahremanlou M, Farahmand L. Evaluating human epidermal growth factor receptor 2 roles in the efficacy of Tamoxifen treatment in breast cancer, a systematic review. Pharmacol Rep 2021;73:435-42. [PMID: 33682068 DOI: 10.1007/s43440-021-00237-z] [Reference Citation Analysis]
12 Zhao Y, Lin Z, Lin Z, Zhou C, Liu G, Lin J, Zhang D, Lin D. Overexpression of Mucin 1 Suppresses the Therapeutical Efficacy of Disulfiram against Canine Mammary Tumor. Animals (Basel) 2020;11:E37. [PMID: 33375426 DOI: 10.3390/ani11010037] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Zhou J, Su CM, Chen HA, Du S, Li CW, Wu H, Tsai SH, Yeh YT. Cryptanshinone Inhibits the Glycolysis and Inhibits Cell Migration Through PKM2/β-Catenin Axis in Breast Cancer. Onco Targets Ther 2020;13:8629-39. [PMID: 32922039 DOI: 10.2147/OTT.S239134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
14 Andey T, Attah MM, Akwaaba-Reynolds NA, Cheema S, Parvin-Nejad S, Acquaah-Mensah GK. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients. Gene X 2020;5:100030. [PMID: 32550556 DOI: 10.1016/j.gene.2020.100030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zhao S, Li X, Yin L, Hou L, Lan J, Zhu X. TCRP1 induces tamoxifen resistance by promoting the activation of SGK1 in MCF‑7 cells. Oncol Rep 2020;43:2017-27. [PMID: 32323833 DOI: 10.3892/or.2020.7577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Wang X, Zhou X, Zeng F, Wu X, Li H. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1. Breast Cancer 2020;27:765-75. [PMID: 32144736 DOI: 10.1007/s12282-020-01075-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
17 Nam SE, Lim W, Jeong J, Lee S, Choi J, Park H, Jung YS, Jung SP, Bae SY. The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry. Breast Cancer Res Treat 2019;177:669-78. [DOI: 10.1007/s10549-019-05357-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
18 Heublein S, Page S, Mayr D, Schmoeckel E, Trillsch F, Marmé F, Mahner S, Jeschke U, Vattai A. Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer. Int J Mol Sci 2019;20:E295. [PMID: 30642093 DOI: 10.3390/ijms20020295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
19 Jing X, Liang H, Hao C, Yang X, Cui X. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer. Oncol Rep 2019;41:801-10. [PMID: 30483806 DOI: 10.3892/or.2018.6887] [Cited by in Crossref: 18] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
20 Guo M, You C, Dou J. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates. Biomed Pharmacother 2018;107:1318-25. [PMID: 30257347 DOI: 10.1016/j.biopha.2018.08.109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
21 Ge Y, Zhang C, Xiao S, Liang L, Liao S, Xiang Y, Cao K, Chen H, Zhou Y. Identification of differentially expressed genes in cervical cancer by bioinformatics analysis. Oncol Lett 2018;16:2549-58. [PMID: 30013649 DOI: 10.3892/ol.2018.8953] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]